跳轉至內容
Merck
全部照片(1)

Key Documents

SML1265

Sigma-Aldrich

波生坦 水合物

≥98% (HPLC)

同義詞:

4-(1,1-二甲基乙基)-N-[6-(2-羟基乙氧基)-5-(2-甲氧基苯氧基)[2,2'-联嘧啶]-4-基]-苯磺酰胺 一水合物, 4-叔丁基-N- [6-(2-羟基乙氧基)-5-(2-甲氧基-苯氧基)-[2,2´]-联嘧啶-4-基]-苯磺酰胺 一水合物, Ro-47-0203

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C27H29N5O6S · H2O
CAS號碼:
分子量::
569.63
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

化驗

≥98% (HPLC)

形狀

powder

顏色

white to beige

溶解度

DMSO: 5 mg/mL, clear (warmed)

儲存溫度

2-8°C

SMILES 字串

O=S(C1=CC=C(C(C)(C)C)C=C1)(NC2=NC(C3=NC=CC=N3)=NC(OCCO)=C2OC4=CC=CC=C4OC)=O.O

InChI

1S/C27H29N5O6S.H2O/c1-27(2,3)18-10-12-19(13-11-18)39(34,35)32-23-22(38-21-9-6-5-8-20(21)36-4)26(37-17-16-33)31-25(30-23)24-28-14-7-15-29-24;/h5-15,33H,16-17H2,1-4H3,(H,30,31,32);1H2

InChI 密鑰

SXTRWVVIEPWAKM-UHFFFAOYSA-N

應用

水合波生坦已用于细胞活力测定。此外,它还被用作钙瞬态分析的阳性对照。

生化/生理作用

已有发现证明,波生坦可减少肺中胶原蛋白沉积——在博来霉素诱导的肺纤维化大鼠模型中观察到此现象。
波生坦是一种内皮素受体拮抗剂。内皮素是一种有效的血管收缩药,因而成为治疗血管痉挛相关疾病(如蛛网膜下腔出血 (SAH) 和高血压)的临床关注拮抗剂。波生坦是一种双重内皮素受体拮抗剂,可有效治疗肺动脉高压(PAH),这是首个投放市场的同类产品。波生坦是 ETA 和 ETB 受体亚型(ETA 的 Ki 为4.7 nM,ETB 的 Ki为95 nM)的竞争性口服拮抗剂。

象形圖

Health hazard

訊號詞

Warning

危險聲明

危險分類

Aquatic Chronic 3 - Repr. 2

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 2

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myeloma.
Russignan A, et al.
British Journal of Haematology, 178(5), 781-793 (2017)
BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis.
King Jr T E, et al.
American Journal of Respiratory and Critical Care Medicine, 177(1), 75-81 (2008)
Molecular phenotyping combines molecular information, biological relevance, and patient data to improve productivity of early drug discovery.
Drawnel F M, et al.
Cell Chemical Biology, 24(5), 624-634 (2017)
Fuhua Yang et al.
Toxicological sciences : an official journal of the Society of Toxicology, 170(1), 95-108 (2019-04-16)
The bile salt export pump (BSEP, ABCB11) mediates bile acid efflux from hepatocytes into bile. Although the inhibition of BSEP has been implicated as an important mechanism of drug-induced liver injury (DILI), liver injury caused by BSEP-inhibiting drugs is rarely
Xiaomin Liang et al.
Drug metabolism and disposition: the biological fate of chemicals, 48(12), 1283-1292 (2020-10-11)
It is well documented that human hepatic clearance based on in vitro metabolism or transporter assays systematically resulted in underprediction; therefore, large empirical scalars are often needed in either static or physiologically based pharmacokinetic (PBPK) models to accurately predict human

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務